KSC · 207940.KS
Samsung Biologics Co.,Ltd.
₩1,487,000+₩121,000 (+8.86%)
Samsung Biologics Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 25.16% below the high.
Loading market information…
KSC · 002390.KS · KRW
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 06:30 AM UTC. Cached market data; not a live quote.
One-year closing-price history · KRW. Historical prices are not a forecast.
HANDOK Inc.’s quoted price sits in the lower half of its reported 52-week range, 32.43% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
HANDOK Inc.’s forward annual dividend is ₩200 per share, paid annual. The forward yield is 2.44% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
HANDOK Inc.’s next earnings report is currently expected on Nov 18, 2026. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow HANDOK Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
HANDOK Inc. operates as a pharmaceutical company. The company provides prescription and OTC drugs; medical devices, such as blood pressure monitors, cholesterol monitoring systems, insulin pumps, self-monitoring system of blood glucose, and blood glucose monitoring system; in vitro diagnostic medical devices; as well as life science products. It also offers healthcare products comprising food supplements under the NatureSet brand; food and beverages; and medical nutrition products. In addition, the company engages in real estate leasing. The company was formerly known as Handok Pharmaceuticals Co., Ltd and changed its name to Handok Inc. in July 2013. Handok Inc. was founded in 1954 and is headquartered in Seoul, South Korea.
Latest available per-share figures in KRW. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 10:46 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| Q3 2024 | Oct 31, 2024 | -₩241 | ₩129.04B-3.7% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
₩1,487,000+₩121,000 (+8.86%)
Samsung Biologics Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 25.16% below the high.
₩191,600+₩2,300 (+1.22%)
Celltrion, Inc.’s quoted price sits in the lower half of its reported 52-week range, 19.85% below the high.
₩75,100+₩400 (+0.54%)
Yuhan Corporation’s quoted price sits in the lower half of its reported 52-week range, 41.87% below the high.
₩86,900+₩600 (+0.7%)
Dong-A Socio Holdings Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 30.76% below the high.
₩23,000-₩150 (-0.65%)
JW Pharmaceutical Corporation’s quoted price sits in the lower half of its reported 52-week range, 41.4% below the high.
CA$3.51-CA$0.17 (-4.62%)
Tilray Brands, Inc.’s quoted price sits in the lower half of its reported 52-week range, 83.73% below the high.
₩35,600+₩200 (+0.56%)
Chong Kun Dang Holdings Corp.’s quoted price sits in the lower half of its reported 52-week range, 35.97% below the high.
₩5,100-₩60 (-1.16%)
Dongwha Pharm.Co.,Ltd’s quoted price sits in the lower half of its reported 52-week range, 32.54% below the high.
